AIRNEXIS THERAPEUTICS
Live / Applied — New application — not yet assigned to an examiner (as of 27 Oct 2026)
What this means for you
Not registered yet, but its 27 Oct 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50185473
- Mark type
- Design + words
- Filed
- 27 Oct 2026
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for the treatment, control, prevention, maintenance, and management of inflammatory and respiratory diseases and symptoms in humans; anti-inflammatory and immunomodulatory pharmaceutical compositions; medications for respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), bronchitis, cystic fibrosis, pneumonia, allergic rhinitis, Idiopathic Pulmonary Fibrosis (IPF), bronchiectasis, chronic cough and other pulmonary disorders; pharmaceutical compositions in the form of tablets, capsules, liquids, aerosols, inhalers, creams, ointments, gels, and injectables for the treatment of inflammatory and respiratory diseases and symptoms in humans; fixed-dose combination pharmaceutical preparations for inflammatory and respiratory diseases and symptoms in humans; combination pharmaceutical preparations comprising two or more active ingredients for inflammatory and respiratory diseases and symptoms in humans; pharmaceutical preparations for use in combination therapy for inflammatory and respiratory diseases and symptoms in humans
- Class 042 — Scientific and technological services: Research, development, and formulation being research and development of pharmaceuticals for inflammatory and respiratory diseases; pharmaceutical formulation in the nature of pharmaceutical research and development services in the field of inflammatory and respiratory diseases
- Class 044 — Medical, beauty and agricultural services: Formulation of pharmaceuticals, namely, pharmaceutical compounding for inflammatory and respiratory diseases; pharmaceutical formulation, namely, pharmaceutical compounding services in the field of inflammatory and respiratory diseases
Owner
- AirNexis Therapeutics, Inc., Redwood City, CA, US
Prosecution history
- 27 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Oct 2026 — NEW APPLICATION ENTERED